image
AnaptysBio, Inc. ANAB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 20.12
-2.94 %
$ 617 M
Market Cap
-3.93
P/E
BALANCE SHEET
484 M ASSETS
6.95%
Growth Rates
1Year 6.95%
3Years -9.05%
5Years 2.14%
7Years 5.65%
10Years 34.45%
413 M LIABILITIES
13.36%
Growth Rates
1Year 13.36%
3Years 12.94%
5Years 68.74%
7Years 52.24%
10Years 36.00%
70.9 M EQUITY
-19.56%
Growth Rates
1Year -19.56%
3Years -41.63%
5Years -29.43%
7Years -18.92%
10Years 28.02%
BALANCE SHEET DECOMPOSITION
Balance Sheet AnaptysBio, Inc.
image
Current Assets 432 M
Cash & Short-Term Investments 385 M
Receivables 40.8 M
Other Current Assets 5.74 M
Non-Current Assets 52 M
Long-Term Investments 35.5 M
PP&E 16.2 M
Other Non-Current Assets 256 K
79.65 %8.43 %7.33 %3.35 %Total Assets$483.8m
Current Liabilities 45.4 M
Accounts Payable 4 M
Short-Term Debt 1.92 M
Other Current Liabilities 39.5 M
Non-Current Liabilities 368 M
Long-Term Debt 0
Other Non-Current Liabilities 368 M
9.57 %89.00 %Total Liabilities$413.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 123.1 36.0 71.3 495.7 250.5 171.0 113.6 81.2 51.2 51.7 22.2 2.8
Short Term Investments 262.3 354.9 369.9 52.4 143.2 203.2 313.5 167.2 0 0 0 0
Receivables 40.8 6.9 1.4 0.9 0 0 0.2 1.6 5.3 1.2 1.5 0
Inventory 0 0 1 1 0 0 0 0 1 0 0 0
Other Current Assets 5.7 9.1 4.5 4.9 5.8 7.0 7.0 2.7 1.6 1.1 1.5 0.2
Total Current Assets 431.9 406.8 447.2 553.9 396.6 377.7 434.2 252.7 58.2 53.5 24.4 3.1
PP&E 16.2 18.3 20.0 21.8 1.8 1.6 1.4 0.7 0.5 0.6 0.6 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 35.5 27.0 142.9 67.1 17.5 54.3 73.1 75.9 60 K 60 K 0 0
Other Long Term Assets 0.3 0.3 0.3 0.3 0.7 1.5 0.2 0.1 3.4 2.2 85 K 0.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 483.8 452.4 610.4 643.1 416.6 435.2 509.0 329.4 62.2 56.3 25.1 3.9
LIABILITIES
Accounts Payable 4.0 4.7 2.8 1.7 4.2 16.2 5.4 2.3 2.3 1.5 0.4 0.2
Short Term Debt 1.9 1.8 3.3 3.0 0.3 2.2 7.6 6.9 1 K 21 K 0.1 0.9
Other Current Liabilities 39.5 31.0 20.0 11.3 15.3 11.1 8.8 4.9 3.4 2.8 1.1 0.7
Total Current Liabilities 45.4 37.4 26.1 16.1 19.8 29.5 21.8 14.1 5.7 7.4 11.7 3.2
Long Term Debt 0 16.0 17.8 19.4 0 0.7 0.6 7.6 13.8 4.9 4.8 0
Deferred Tax Income 0 0 0 0 0 0 (0.2) (0.1) (0.2) (0.1) 0 0
Other Liabilities 367.5 310.8 304.4 251.1 0 0 0.2 0.1 3.4 1.7 0.6 0.6
Total Liabilities 413.0 364.3 348.3 286.6 19.8 30.2 22.6 21.8 22.9 13.9 19.1 3.8
EQUITY
Common Stock 30 K 27 K 29 K 28 K 27 K 27 K 27 K 24 K 3 K 3 K 17 K 17 K
Retained Earnings (759.3) (614.1) (450.5) (321.8) (264.0) (244.0) (146.7) (85.0) (54.9) (50.7) (45.3) (48.8)
Other Accumulative Comprehensive Income/Loss 0.3 (0.8) (5.2) (0.4) 4 K 0.3 (0.2) (0.4) (3.8) (3.6) (3.4) (3.1)
Total Equity 70.9 88.1 262.1 356.4 396.7 405.0 486.4 307.6 39.3 42.3 6.0 0.1
Total Liabilities and Equity 483.8 452.4 610.4 643.1 416.6 435.2 509.0 329.4 62.2 56.3 25.1 3.9
SHARES OUTSTANDING
Common Shares Outstanding 28.4 26.9 28.2 27.4 27.3 27.1 24.7 19.8 18.2 14.2 14.2 5.85